BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38049848)

  • 1. Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
    Blázquez-Encinas R; García-Vioque V; Caro-Cuenca T; Moreno-Montilla MT; Mangili F; Alors-Pérez E; Ventura S; Herrera-Martínez AD; Moreno-Casado P; Calzado MA; Salvatierra Á; Gálvez-Moreno MA; Fernandez-Cuesta L; Foll M; Luque RM; Alcala N; Pedraza-Arevalo S; Ibáñez-Costa A; Castaño JP
    J Transl Med; 2023 Dec; 21(1):879. PubMed ID: 38049848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors.
    Pedraza-Arevalo S; Alors-Pérez E; Blázquez-Encinas R; Herrera-Martínez AD; Jiménez-Vacas JM; Fuentes-Fayos AC; Reyes Ó; Ventura S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Gálvez-Moreno MA; Gahete MD; Ibáñez-Costa A; Luque RM; Castaño JP
    Transl Res; 2023 Jan; 251():63-73. PubMed ID: 35882361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication.
    Shkreta L; Delannoy A; Salvetti A; Chabot B
    RNA; 2021 Nov; 27(11):1302-1317. PubMed ID: 34315816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
    Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ
    J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication.
    Shkreta L; Blanchette M; Toutant J; Wilhelm E; Bell B; Story BA; Balachandran A; Cochrane A; Cheung PK; Harrigan PR; Grierson DS; Chabot B
    Nucleic Acids Res; 2017 Apr; 45(7):4051-4067. PubMed ID: 27928057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CASH: a constructing comprehensive splice site method for detecting alternative splicing events.
    Wu W; Zong J; Wei N; Cheng J; Zhou X; Cheng Y; Chen D; Guo Q; Zhang B; Feng Y
    Brief Bioinform; 2018 Sep; 19(5):905-917. PubMed ID: 28387786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRSF10 Plays a Role in Myoblast Differentiation and Glucose Production via Regulation of Alternative Splicing.
    Wei N; Cheng Y; Wang Z; Liu Y; Luo C; Liu L; Chen L; Xie Z; Lu Y; Feng Y
    Cell Rep; 2015 Nov; 13(8):1647-57. PubMed ID: 26586428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production.
    Chabrolles H; Auclair H; Vegna S; Lahlali T; Pons C; Michelet M; Couté Y; Belmudes L; Chadeuf G; Kim Y; Di Bernardo A; Jalaguier P; Cosset FL; Fusil F; Rivoire M; Arnold LD; Lopatin U; Combet C; Zoulim F; Grierson D; Chabot B; Lucifora J; Durantel D; Salvetti A
    PLoS Pathog; 2020 Nov; 16(11):e1008593. PubMed ID: 33180834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair Factors.
    Shkreta L; Toutant J; Durand M; Manley JL; Chabot B
    Cell Rep; 2016 Nov; 17(8):1990-2003. PubMed ID: 27851963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
    Ibáñez-Costa A; Perez-Sanchez C; Patiño-Trives AM; Luque-Tevar M; Font P; Arias de la Rosa I; Roman-Rodriguez C; Abalos-Aguilera MC; Conde C; Gonzalez A; Pedraza-Arevalo S; Del Rio-Moreno M; Blazquez-Encinas R; Segui P; Calvo J; Ortega Castro R; Escudero-Contreras A; Barbarroja N; Aguirre MA; Castaño JP; Luque RM; Collantes-Estevez E; Lopez-Pedrera C
    Ann Rheum Dis; 2022 Jan; 81(1):56-67. PubMed ID: 34625402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage.
    Cloutier A; Shkreta L; Toutant J; Durand M; Thibault P; Chabot B
    Sci Rep; 2018 Feb; 8(1):2206. PubMed ID: 29396485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis.
    Krach F; Wheeler EC; Regensburger M; Boerstler T; Wend H; Vu AQ; Wang R; Reischl S; Boldt K; Batra R; Aigner S; Ravits J; Winkler J; Yeo GW; Winner B
    Acta Neuropathol; 2022 Sep; 144(3):413-435. PubMed ID: 35778567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
    Qu L; Tian Y; Wang F; Li Z
    BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRSF10 regulates alternative splicing and is required for adipocyte differentiation.
    Li H; Cheng Y; Wu W; Liu Y; Wei N; Feng X; Xie Z; Feng Y
    Mol Cell Biol; 2014 Jun; 34(12):2198-207. PubMed ID: 24710272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing.
    Liu W; Lu X; Zhao ZH; Su R; Li QL; Xue Y; Gao Z; Sun SS; Lei WL; Li L; An G; Liu H; Han Z; Ouyang YC; Hou Y; Wang ZB; Sun QY; Liu J
    Elife; 2022 Nov; 11():. PubMed ID: 36355419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRSF10 facilitates HCC growth and metastasis by suppressing CD8
    Luo X; Zhang Z; Li S; Wang Y; Sun M; Hu D; Jiang J; Wang Y; Ji X; Chen X; Zhang B; Liang H; Li Y; Liu B; Xu X; Wang S; Xu S; Nie Y; Wu K; Fan D; Liu D; Huang W; Xia L
    Int Immunopharmacol; 2024 Jan; 127():111376. PubMed ID: 38113691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids.
    Rapa I; Votta A; Giorcelli J; Izzo S; Rigutto A; Metovic J; Napoli F; Volante M
    Neuroendocrinology; 2021; 111(1-2):115-122. PubMed ID: 32040954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.
    Chang C; Rajasekaran M; Qiao Y; Dong H; Wang Y; Xia H; Deivasigamani A; Wu M; Sekar K; Gao H; Sun M; Niu Y; Li Q; Tao L; Yan Z; Wang M; Chen S; Zhao S; Chen D; Li L; Yang F; Gao H; Chen B; Su L; Xu L; Chen Y; Seshachalam VP; Chen G; Gunaratne J; Hong W; Shi J; Chen G; Grierson DS; Chabot B; Xie T; Hui KM; Chen J
    Nat Commun; 2022 Mar; 13(1):1363. PubMed ID: 35296659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.